Business · 02/04/2008Updated: 10/17/2026 · 1 min read
FDA Determines Regulatory Review Period for ACRYSOF Patent Extension
Summary
The Food and Drug Administration (FDA) has officially confirmed the regulatory review period for ACRYSOF, a medical device patent extension application submitted to the Department of Commerce, as required by law.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →